ANIK - Anika Therapeutics, Inc.
NEXT EARNINGS:
May 8, 2026
EPS Est: $-0.07
|
Rev Est: $28.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
213.43M
Volume:
99,105
Avg Volume:
145,395
52 Week Range:
7.87-15.18
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.28
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
288
IPO Date:
1993-05-03
EPS (TTM):
-0.76
P/E Ratio:
-12.67
Revenue (TTM):
112.82M
Total Assets:
190.27M
Total Debt:
24.20M
Cash & Equiv:
57.48M
Rev Growth (5Y):
-2.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-17.5%
ROCE (5Y avg):
-2.3%
ROE (5Y avg):
-17.4%
Debt/Equity:
0.17
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-26 | $0.31 | $-0.12 | +348.0% | $30.6M | $28.9M | +6.0% |
| 2025-11-05 | $0.04 | $0.02 | +100.0% | $27.8M | $27.8M | 0.0% |
| 2025-07-30 | $-0.13 | $-0.13 | 0.0% | $28.2M | $27.5M | +2.5% |
| 2025-05-09 | $-0.06 | $0.09 | -166.7% | $26.2M | $28.1M | -6.8% |
| 2025-03-12 | $-0.03 | $-0.01 | -200.0% | $-1290000 | $28.1M | -104.6% |
| 2024-10-31 | $-0.25 | $0.30 | -183.3% | $38.8M | $29.0M | +33.6% |
| 2024-08-08 | $0.17 | $0.23 | -26.1% | $41.9M | $42.1M | -0.4% |
| 2024-05-08 | $-0.31 | $-0.19 | -63.2% | $40.5M | $39.2M | +3.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 112.82M | 119.91M | 120.79M | 113.83M | 147.79M | 130.46M | 114.61M | 105.56M | 113.42M | 103.38M | 93.00M | 105.59M |
| Net Income | (10.88M) | (56.38M) | (82.67M) | (14.86M) | 4.13M | (23.98M) | 27.19M | 18.72M | 31.82M | 32.55M | 30.76M | 38.32M |
| EPS | -0.76 | -3.83 | -5.64 | -1.02 | 0.29 | -1.69 | 1.93 | 1.30 | 2.18 | 2.22 | 2.06 | 2.61 |
| Total Assets | 190.27M | 202.74M | 270.63M | 349.13M | 347.54M | 365.61M | 330.71M | 278.99M | 282.62M | 240.25M | 235.75M | 194.00M |
| Total Debt | 24.20M | 25.93M | 27.74M | 30.89M | 20.95M | 22.46M | 22.51M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 57.48M | 55.63M | 68.74M | 86.33M | 94.39M | 95.82M | 157.46M | 89.04M | 133.26M | 104.26M | 110.71M | 100.16M |
| Operating Cash Flow | 11.19M | 5.40M | (1.79M) | 4.41M | 8.40M | 13.06M | 37.01M | 34.92M | 40.81M | 23.80M | 39.06M | 39.98M |
| Free Cash Flow | 4.36M | (2.33M) | (7.21M) | (3.08M) | 3.25M | 11.44M | 34.18M | 30.26M | 31.83M | 9.79M | 29.84M | 38.43M |
| FCF per Share | 0.30 | -0.16 | -0.49 | -0.21 | 0.23 | 0.80 | 2.42 | 2.10 | 2.18 | 0.67 | 2.00 | 2.62 |
| Book Value | 143.47M | 153.99M | 212.26M | 285.56M | 287.08M | 272.40M | 288.38M | 263.61M | 263.49M | 222.77M | 210.85M | 178.10M |
| Cash & ST Investments | 57.48M | 55.63M | 68.74M | 86.33M | 94.39M | 98.32M | 184.94M | 159.01M | 157.26M | 124.76M | 138.46M | 106.91M |
| Return on Equity | -0.08 | -0.37 | -0.39 | -0.05 | 0.01 | -0.09 | 0.09 | 0.07 | 0.12 | 0.15 | 0.15 | 0.22 |
| Return on Capital Employed | -0.04 | -0.03 | 0.00 | 0.01 | -0.06 | -0.04 | 0.11 | 0.08 | 0.17 | 0.22 | 0.22 | 0.33 |